Browsing Tag
AI in biotech
5 posts
From 10X Genomics to Takara Bio: what LatchBio’s massive spatial atlas means for biotech
LatchBio releases a 25 million cell spatial atlas spanning 11 platforms and 63 diseases. Discover how this AI-ready data is transforming spatial biology.
What is the Luma platform by Dotmatics and why is Siemens betting on it for life sciences R&D?
Explore how Luma by Dotmatics stacks up against Benchling and Thermo Fisher in AI-powered scientific R&D. Is Siemens building a new category?
Miraomics, Pythia Biosciences and LatchBio unveil 30 million cell atlas and AI-powered curation framework for molecular data
Miraomics, Pythia Biosciences, and LatchBio release a 30M cell atlas and launch AI tools for high-efficiency curation of molecular datasets. Explore industry impact.
XtalPi acquires Liverpool ChiroChem in bid to dominate chiral AI-driven chemical discovery
XtalPi’s acquisition of Liverpool ChiroChem integrates AI-driven chiral chemistry to scale next-gen molecular innovation—read more now.
Recursion Pharmaceuticals (NASDAQ: RXRX) stock rises after 20% workforce cut and pipeline reset
Recursion Pharmaceuticals (NASDAQ: RXRX) cuts 20% of workforce to extend runway and narrow pipeline focus—read what this means for its AI drug discovery strategy.